CNR1 and neoplasm: Generally, the excessive activation of the endocannabinoid system may accelerate some physiological processes responsible for tumor inhibition and reduction of melanoma cell viability, but it may evoke some cannabinoid-specific adverse effects, being the result of excessive activation of CB1 and CB2 receptors.